Azora Therapeutics Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

107.80%

Shs. 5Y

—

Rev. 5Y

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.

URL

https://www.azoratherapeutics.com/

IPO date

Employees

Domiciled in

Incorporated in

Valuation

No data to show